1. Home
  2. MDXH vs WIMI Comparison

MDXH vs WIMI Comparison

Compare MDXH & WIMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • WIMI
  • Stock Information
  • Founded
  • MDXH 2003
  • WIMI 2015
  • Country
  • MDXH Belgium
  • WIMI China
  • Employees
  • MDXH N/A
  • WIMI N/A
  • Industry
  • MDXH
  • WIMI Computer Software: Prepackaged Software
  • Sector
  • MDXH
  • WIMI Technology
  • Exchange
  • MDXH Nasdaq
  • WIMI Nasdaq
  • Market Cap
  • MDXH 78.3M
  • WIMI 74.7M
  • IPO Year
  • MDXH 2021
  • WIMI 2020
  • Fundamental
  • Price
  • MDXH $2.53
  • WIMI $0.84
  • Analyst Decision
  • MDXH Strong Buy
  • WIMI
  • Analyst Count
  • MDXH 2
  • WIMI 0
  • Target Price
  • MDXH $7.50
  • WIMI N/A
  • AVG Volume (30 Days)
  • MDXH 44.6K
  • WIMI 285.8K
  • Earning Date
  • MDXH 11-06-2024
  • WIMI 01-01-0001
  • Dividend Yield
  • MDXH N/A
  • WIMI N/A
  • EPS Growth
  • MDXH N/A
  • WIMI N/A
  • EPS
  • MDXH N/A
  • WIMI N/A
  • Revenue
  • MDXH $80,741,000.00
  • WIMI $82,551,712.00
  • Revenue This Year
  • MDXH $24.45
  • WIMI N/A
  • Revenue Next Year
  • MDXH $15.22
  • WIMI N/A
  • P/E Ratio
  • MDXH N/A
  • WIMI N/A
  • Revenue Growth
  • MDXH 45.51
  • WIMI N/A
  • 52 Week Low
  • MDXH $0.35
  • WIMI $0.56
  • 52 Week High
  • MDXH $4.64
  • WIMI $1.87
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 37.08
  • WIMI 53.76
  • Support Level
  • MDXH $2.84
  • WIMI $0.73
  • Resistance Level
  • MDXH $2.74
  • WIMI $0.83
  • Average True Range (ATR)
  • MDXH 0.12
  • WIMI 0.04
  • MACD
  • MDXH -0.05
  • WIMI 0.01
  • Stochastic Oscillator
  • MDXH 0.00
  • WIMI 90.00

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

About WIMI WiMi Hologram Cloud Inc.

WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings primarily consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.

Share on Social Networks: